tiprankstipranks
Advertisement
Advertisement
Enanta’s New RSV Trial in Infants: What Investors Should Watch in ENTA
PremiumCompany AnnouncementsEnanta’s New RSV Trial in Infants: What Investors Should Watch in ENTA
2M ago
Enanta Shareholders Approve Board Elections and Equity Plan
Premium
Company Announcements
Enanta Shareholders Approve Board Elections and Equity Plan
2M ago
Enanta Pharmaceuticals: RSV Monoclonal Headwinds Turn Tailwind for Zelicapavir Treatment Opportunity
Premium
Ratings
Enanta Pharmaceuticals: RSV Monoclonal Headwinds Turn Tailwind for Zelicapavir Treatment Opportunity
3M ago
Enanta Pharmaceuticals Reports Progress in Drug Development
PremiumCompany AnnouncementsEnanta Pharmaceuticals Reports Progress in Drug Development
6M ago
Enanta reports Q4 EPS (87c), consensus ($1.01)
Premium
The Fly
Enanta reports Q4 EPS (87c), consensus ($1.01)
6M ago
Is ENTA a Buy, Before Earnings?
Premium
Pre-Earnings
Is ENTA a Buy, Before Earnings?
6M ago
Enanta upgraded to Buy at Jefferies on higher confidence in RSV antiviral
PremiumThe FlyEnanta upgraded to Buy at Jefferies on higher confidence in RSV antiviral
8M ago
Enanta 6.5M share Spot Secondary priced at $10.00
Premium
The Fly
Enanta 6.5M share Spot Secondary priced at $10.00
8M ago
Closing Bell Movers: Nike rallies 4% after earnings beat and guidance
Premium
The Fly
Closing Bell Movers: Nike rallies 4% after earnings beat and guidance
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100